Precision BioSciences Inc. (NASDAQ:DTIL)
Old Forum Content for DTIL
Make a Forum Post Become a member to view recent forum posts. Already a member? Sign in here.
- issues: Sold some $CZZ and $CLSD. Took some profits on the rocket ride $APLT, but kept 1/2. Totally out of $ISEE. Do you see? I see. Bought $APLS and added to $DTIL, $ORCL and $NTCO (Avon). Could'nt resist $WBA on this major pull back. Of course I put in a stop.
- issues: Bought small positions in these biotechs: $BDSI $JNCE (flag/phase 2 pattern) $PFNX $AKBA $HZNP $NK $APTO $AMRN. Also added to $DTIL.
- Herb: $DTIL wtf?
- shoredriver: @Herb $DTIL ...what does your Kiwi friend say??
- DrScience: @Herb $DTIL Why the fall? One word -- Data! Many, many presentations and data releases for ongoing or upcoming conference! American Epilepsy Society, or AES, 2019 Annual Meeting – Dec. 6-10 in Baltimore, Maryland 61st American Society of Hematology, or ASH, Annual Meeting – Dec. 7-10 in Orlando, Florida San Antonio Breast Cancer Symposium, or SABCS, 2019 – Dec. 10-14 in San Antonio, Texas European Society of Medical Oncology, or ESMO, Immuno-Oncology Congress – Dec. 11-14, in Geneva, Switzerland
- Herb: @shoredriver $DTIL Just emailed him. He probably doesn't follow this one.
- numbers: $DTIL - ATH
- Sher: $DTIL - Not sure what's causing a 25% jump in price, today - No news that I can find - This fairly recent IPO has been in hemorrhage mode, forever - I nearly closed out my position, this morning, at what would have been a huge loss - I really hope somebody buys this dog...
- champ: @Sher $DTIL --- At a conference today and also will be at others on 12th, 14th, and the 17th, plus a upgrade on 9/9, with a new target at $22.00
- Sher: @champ $DTIL - Thanks, Champ! Knew about the conferences, but completely missed the upgrade... My only attempt at trading an IPO and I got pretty skunked on this one! No excuses and no stops in place... just kept thinking a bottom was just on the horizon (nope). Won't do that again!
- champ: @Sher $DTIL --- Companies at conferences can really move their stock price, if they have positive news, the Rule of Thumb is, they must have something to spin or they wouldn't be there.....
- Sher: $DTIL conference update: Precision BioSciences up 22% after medical conference event Sep. 11, 2019 3:25 PM ET|About: Precision BioSciences,... (DTIL)|By: Douglas W. House, SA News Editor Thinly traded Precision BioSciences (DTIL +21.7%) is up on almost a 4x surge in volume after a panel discussion today at the CAR-TCR Summit in Boston moderated by Chief Medical Officer Chris Heery, M.D. The topic was "Ensuring CAR-TCR therapies are accessible to patients." Whatever was said, investors liked it. The company is developing cell-based immunotherapies utilizing its ARCUS genome editing technology which, it says, ensures maximum gene editing efficiency with minimal off-target activity.
- spmeyers: $DTIL recent IPO, been building a base for 2 months, broke out Thursday, could run more
- coldevinc: @spmeyers $DTIL Looks like a day three bull trap to me.
- Sher: $SWAV – “Jumpin”… One of the better performing recent IPOs – Up 16.5%, today, following earnings beat, and 60% since opening, 3-7-19. No, I did not buy this fine-performing IPO, but opted, instead, to go with $DTIL, which lost its bearing while still in the gate…
-
Sher: ...
$DTIL (genome editing) – Recent IPO that’s been flailing since opening – It was priced @ $16/share, opened @ $18/share, hit a high of $19 and low of $17 – It eventually plunged to a low of $14.33/share – With today&rsqu ... - Sher: $DTIL - Precision BioSciences makes its IPO debut today; a genome editing company. While investors are eagerly awaiting Lyft's IPO tomorrow, another name is making its IPO debut today: Precision BioSciences (DTIL). Last night, it priced its 7.9 mln share IPO at $16 per share, the midpoint of the expected range of $15-17. DTIL is a genome editing company. It leverages its genome editing platform, called ARCUS, in the development of drugs that treat human diseases and it's used to create healthy and sustainable food and agricultural options. Currently trading @ $18.18
- Sher: $DTIL update: Opened @ $18, high of $19/low of $17.16 and currently @ $17.56 - 3.5M shares have traded... AM post: $DTIL - Precision BioSciences makes its IPO debut today; a genome editing company. While investors are eagerly awaiting Lyft's IPO tomorrow, another name is making its IPO debut today: Precision BioSciences (DTIL). Last night, it priced its 7.9 mln share IPO at $16 per share, the midpoint of the expected range of $15-17. DTIL is a genome editing company. It leverages its genome editing platform, called ARCUS, in the development of drugs that treat human diseases and it's used to create healthy and sustainable food and agricultural options. Currently trading @ $18.18
| Stock Price | $6.88 |
| Change | -0.72% |
| Volume | 849,843 |
Already a member? Sign in here.
Past Month
Leading Peers
-
$7.33 195.27%
-
$6.48 178.25%
-
$5.00 93.65%
Past Month
Lagging Peers
-
$12.54 -175.86%
-
$6.85 -49.52%
-
$14.55 -43.99%
Dan Fitzpatrick
Stock Market Mentor gives you EVERYTHING you need to succeed in the market; all in one place. How easy is that? Dan Fitzpatrick and his elite community of traders share trading ideas, strategies and much more. Dan Fitzpatrick--a world class Technical Analyst, trading coach and regular CNBC contributor--gives you access to all of this with a 30 day trial membership for just $7.77. Get started TODAY and start trading better TOMORROW with the following premium content:
- Nightly video Strategy Sessions with a game plan for tomorrow
- Got a stock you want Dan to look at? Just ask.
- Patent pending video alerts instantly delivered to you when one of Dan’s trading signals is triggered. This is not your typical price alert. This is a short video explaining the action you need to take to make money. No more “Woulda, coulda, shoulda”
- Access to over 90,400 stock analysis videos
- Access an ever expanding library (90,400) of educational videos that will save you time and make you money
Join a team of friends and traders that have one thing in common; a burning desire to succeed.
Become a Member Today!
Gain immediate access to all our exclusive articles, features, how-to's, discussion group and much more...
Satisfaction Guaranteed!
Your Stock Market Mentor membership comes with a 30 day, no questions asked, 100% money back guarantee!